Medserv announced unaudited consolidated earnings results for six months Ended June 30, 2018. For the period, the company announced revenue of EUR 18,137,739 compared to EUR 13,619,788 a year ago. Results from operating activities of EUR 1,016,418 compared to EUR 1,155,269 a year ago. Loss before income tax of EUR 2,673,907 compared to EUR 3,354,106 a year ago. Loss for the period attributable to owner of the company of EUR 2,398,103 compared to EUR 3,663,321 a year ago. Basic loss per share of 4.5 cents compared to 6.8 cents a year ago. Net cash from operating activities of EUR 4,300,267 compared to EUR 2,208,112 a year ago. Acquisition of property plant and equipment of EUR 5,415,549 compared to EUR 264,711 a year ago. Adjusted EBITDA of EUR 3,396,702 compared to EUR 2,865,388 a year ago.